MYCOPHENOLATE MOFETİL TREATMENT IN PRIMARY GLOMERULONEPHRITIS THAT IS RESISTANT TO TREATMENT (RETROSPECTIVE ANALYSIS)
The success rate of different treatment protocols for primary glomerulonephritis (PGN) is 60-70%. Recently, it has been suggested that in somel patients who are unresponsive to standard treatments, \ mycophenolate mofetil (MMF)- the pro-drug of mycophenolic acid- can be used. In our study, the \ res...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Turkish Society of Nephrology
2019-03-01
|
| Edice: | Turkish Journal of Nephrology |
| Témata: | |
| On-line přístup: | https://turkjnephrol.org/index.php/pub/article/view/304 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
